Company news
Medtide, Inc. news in 2026
Medtide, Inc.'s news releases, calls and decks from 2026, newest first.
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
November 4, 2026
Rules relating to the 2026 restricted share unit scheme
November 3, 2026
Form of proxy for the 2026 extraordinary general meeting to be held on Wednesday, November 18, 2026
October 29, 2026
Notice of extraordinary general meeting
October 29, 2026
2026 EGM Circular
October 29, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
October 6, 2026
Voluntary announcement update on the strategic expansion of large-scale peptide CDMO production capacity
September 24, 2026
List of directors and their roles and functions
September 24, 2026
Resignation of executive director
September 24, 2026
Notification Letter and Reply Form to Non-registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
September 24, 2026
Notification Letter and Reply Form to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
September 24, 2026
2026 Interim report
September 24, 2026
CPC Scientific Announces U.S. FDA Pre-License Inspection (PLI) Successfully Completed at Its Hangzhou cGMP Manufacturing Facility for Hepcludex® API, Establishing a Proven Track Record Under the Stringent BLA Pathway
August 5, 2026
Articles of association
June 18, 2026